Health Canada
- Status: approved
🇨🇦 Interleukin 2 Receptor Antagonist in Canada
Interleukin 2 Receptor Antagonist (Interleukin 2 Receptor Antagonist) regulatory status in Canada.
Marketing authorisation
Interleukin 2 Receptor Antagonist in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Interleukin 2 Receptor Antagonist approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Interleukin 2 Receptor Antagonist in Canada?
University of Khartoum is the originator. The local marketing authorisation holder may differ — check the official source linked above.